Predictors of Stroke in Patients With Impaired Glucose Tolerance

Background and Purpose—Risk factors for stroke are well-established in general populations but sparsely studied in individuals with impaired glucose tolerance.

Methods—We identified predictors of stroke among participants with impaired glucose tolerance in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial. Cox proportional-hazard regression models were constructed using baseline variables, including the 2 medications studied, valsartan and nateglinide.Read More